Results 91 to 100 of about 6,940,670 (314)

Development and validation of tumor‐to‐blood based nomograms for preoperative prediction of lymph node metastasis in lung cancer [PDF]

, 2021
Yili Fu, Xiaoying Xi, Yanhua Tang, Xin Li, Xin Ye, Bin Hu, Yi Liu   +6 more
openalex   +1 more source

Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines

Molecular Oncology, EarlyView.
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad, Mahmood Hachim, Tom Bertin, Karolina Penderecka, Rifat Hamoudi, Saif Khan, Rui Henrique, Natalie Bergmoser, Manit Arya, Kalle Sipila, Matteo Vietri Rudan, Asif Muneer, Aamir Ahmed   +12 more
wiley   +1 more source

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer [PDF]

, 2006
Junichi Soh, Shinichi Toyooka, Keisuke Aoe, Hiroaki Asano, Syuji Ichihara, Hideki Katayama, Akio Hiraki, Katsuyuki Kiura, Motoi Aoe, Yoshifumi Sano, Kazuro Sugi, Nobuyoshi Shimizu, Hiroshi Date   +12 more
openalex   +1 more source

Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study [PDF]

, 2022
Oliver Illini, Hannah Fabikan, Maximilian J. Hochmair, Christoph Weinlinger, Dagmar Krenbek, Luka Brčić, Ulrike Setinek, Angelika Terbuch, Gudrun Absenger, Selma Konjić, Arschang Valipour   +10 more
openalex   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy [PDF]

, 2012
Christina S. Baik, Keith D. Eaton
openalex   +1 more source

Increased activation of cGAS‐STING pathway enhances radiosensitivity of non‐small cell lung cancer cells

, 2022
Aiying Xue, Yue Shang, Peng Jiao, Songling Zhang, Changchun Zhu, Xin He, Guoxing Feng, Saijun Fan   +7 more
openalex   +1 more source

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Chinese Expert Consensus on Standards of PD-L1 Immunohistochemistry Testing 
for Non-small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2020
Chinese Anti-Cancer Association, Lung Cancer Study Group of Committee of Oncopathology, Chinese Society of Lung Cancer, Expert Group on PD-L1 Testing Consensus   +2 more
doaj   +1 more source